期刊文献+

西酞普兰治疗脑卒中后抑郁障碍的对照分析 被引量:4

A comparative study of citalopram in the treatment of post-stroke depression
下载PDF
导出
摘要 目的比较西酞普兰和阿米替林对脑卒中后抑郁障碍的疗效及神经功能康复的影响.方法 62例患者随机分为西酞普兰组和阿米替林组,治疗6周采有汉密尔顿抑郁量表(HAMD)评定疗效.结果西酞普兰组在2~4周末时对脑卒中后抑郁障碍的疗效明显优于阿米替林组,在6周末时两者无明显差异,且西酞普兰组不良反应更少.结论西酞普兰可明显改善脑卒中后抑郁障碍的程度. Objective To compare the effectiveness on depressive symptoms and nervous function of the stroke patients between citalopram and amitripyline.Methods All patients were randomly assigned with citalopram or amitriptyline for 6 weeks.The therapeutic effects were assessed with HAMD scales.Results The findings indicated that the efficacy of citalopram was similar to that of amitriptyline,however paroxetine tool effect more quickly and its side effects were less than that of amitriptyline.Conclusion Paroxetine can significantly improve the depressive symptoms and neurological functions.
出处 《实用神经疾病杂志》 2005年第4期32-33,共2页
关键词 西酞普兰 脑卒中 抑郁障碍 PSD 神经功能 Citalopram Amitriptyline Depressive symptoms Stroke
  • 相关文献

参考文献4

二级参考文献16

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15713
  • 2Morris PL, Robinson RG, Andrzejewski P, et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry, 1993,150(1): 124-129.
  • 3King RB. Quality of life after stroke. Stroke, 1996, 27 (9): 1467-1472.
  • 4Lofgren B, Gustafson Y, Nyberg L. Psychological well-being 3 years after severe stroke. Stroke, 1999, 30(3): 567-572.
  • 5Gordon WA, Hibard MR. Poststroke depression: an examination of the literature. Arch Phys Med Rehabil, 1997, 78(6): 658-663.
  • 6Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after poststroke depression: a double-blind treatment trial.Stroke, 2000, 31 (7): 1482-1486.
  • 7Andersen G, Vestergaard K, Lauritzen L Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke, 1994, 25(6): 1099-1104.
  • 8Wiart L, Petit H, Joseph PA, et al. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000, 31(8): 1829-1832.
  • 9Lane RM, Sweeney M, Henry JA. Pharmacotherapy of the depressed patient with cardiovascular and/or cerebrovascular illness.Br J C1in Pract., 1994, 48(5): 256-262.
  • 10Palomaki H, Kaste M, Berg A, et al. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry, 1999, 66(4): 490-494.

共引文献16004

同被引文献43

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部